QT
LAB icon

Quantbot Technologies’s Standard BioTools LAB Stock Holding History

Quantbot Technologies’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,455
Closed -$25.6K – 1661
2024
Q2 		$25.6K Buy
+14,455
New +$35.3K ﹤0.01% 1316
2021
Q4 		– Sell
-3,168
Closed -$20K – 1720
2021
Q3 		$20K Buy
+3,168
New +$20.8K ﹤0.01% 1267
2021
Q1 		– Sell
-68,081
Closed -$408K – 1607
2020
Q4 		$408K Buy
+68,081
New +$447K 0.04% 478
2020
Q1 		– Sell
-1,406
Closed -$4K – 1151
2019
Q4 		$4K Sell
1,406
-11,850
-89% -$41.7K ﹤0.01% 1141
2019
Q3 		$61K Buy
13,256
+8,983
+210% +$70.8K 0.01% 933
2019
Q2 		$52K Sell
4,273
-23,090
-84% -$294K 0.01% 891
2019
Q1 		$363K Buy
+27,363
New +$288K 0.03% 517
2015
Q4 		– Sell
-2,105
Closed -$17K – 1236
2015
Q3 		$17K Buy
+2,105
New +$33.1K ﹤0.01% 1038
2015
Q1 		– Sell
-791
Closed -$26K – 1212
2014
Q4 		$26K Buy
+791
New +$22.4K 0.01% 922
2014
Q3 		– Sell
-5,525
Closed -$162K – 1269
2014
Q2 		$162K Buy
5,525
+5,125
+1,281% +$164K 0.03% 602
2014
Q1 		$17K Sell
400
-600
-60% -$26.4K ﹤0.01% 980
2013
Q4 		$38K Buy
+1,000
New +$29.5K 0.02% 658

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantbot Technologies's LAB Position: Q3 2024 in Review

Quantbot Technologies sold out of Standard BioTools (LAB) in Q3 2024, closing a stake of 14,455 shares — an estimated $25.6K sold.

Quantbot Technologies first reported a position in LAB in Q4 2013 and held it in 12 quarters. The position peaked at $408K in Q4 2020. 141 funds tracked by Wall St. Rank hold LAB as of Q3 2024.

  • Quantbot Technologies reported no remaining Standard BioTools position as of Q3 2024 after selling out during the quarter.
  • Quantbot Technologies sold 14,455 Standard BioTools shares in Q3 2024, an estimated $25.6K.
  • Quantbot Technologies first reported a position in Standard BioTools in Q4 2013 and held it in 12 quarters.
  • Quantbot Technologies's Standard BioTools position peaked at $408K in Q4 2020.
  • 141 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2024.

Based on Quantbot Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.